These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9132014)

  • 21. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
    Bangalore R; Baindur N; Rutledge A; Triggle DJ; Kass RS
    Mol Pharmacol; 1994 Oct; 46(4):660-6. PubMed ID: 7969044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voltage-dependent calcium channels in skeletal muscle transverse tubules. Measurements of calcium efflux in membrane vesicles.
    Dunn SM
    J Biol Chem; 1989 Jul; 264(19):11053-60. PubMed ID: 2472387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of lacidipine with its receptor binding site supports a slow onset and long duration of action.
    Graziani F; Ratti E; van Amsterdam FT
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):290-6. PubMed ID: 8720430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
    Greenberg DA; Carpenter CL; Messing RO
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel.
    Hockerman GH; Peterson BZ; Sharp E; Tanada TN; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14906-11. PubMed ID: 9405712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
    Schilling WP; Zaher MC; Rampe D
    Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical dihydropyridine binding sites are unaltered in human alcoholic brain.
    Kril JJ; Gundlach AL; Dodd PR; Johnston GA; Harper CG
    Ann Neurol; 1989 Sep; 26(3):395-7. PubMed ID: 2529812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit.
    Regulla S; Schneider T; Nastainczyk W; Meyer HE; Hofmann F
    EMBO J; 1991 Jan; 10(1):45-9. PubMed ID: 1846597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity.
    Mitterdorfer J; Wang Z; Sinnegger MJ; Hering S; Striessnig J; Grabner M; Glossmann H
    J Biol Chem; 1996 Nov; 271(48):30330-5. PubMed ID: 8939992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of dihydropyridine calcium antagonists to membranes from human skeletal muscle.
    Krizanová O; Orlický J; Zachar J
    Gen Physiol Biophys; 1988 Jun; 7(3):324-7. PubMed ID: 2456251
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemical modification of the dihydropyridines binding sites by lysine reagent, pyridoxal 5'-phosphate.
    Costa B; Giusti L; Martini C; Lucacchini A
    Neurochem Int; 1998 Apr; 32(4):361-4. PubMed ID: 9596559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstruction of the dihydropyridine site in a non-L-type calcium channel: the role of the IS6 segment.
    Lacinová L; Klugbauer N; Hu M; Hofmann F
    FEBS Lett; 1999 May; 451(2):152-6. PubMed ID: 10371156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of binding sites for calcium channel antagonists.
    Nakayama H; Kuniyasu A
    Jpn Heart J; 1996 Sep; 37(5):643-50. PubMed ID: 8973377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.